Export of sub-standard drugs by various companies and claiming DEPB /Drawback benefits thereon

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... its thereon. DRI has issues an alert Circular No. 12/2001 from F.No. 50D/9/2001-C1 dated 09.02.2001 on the above subject whereas it appears that certain lesser known companies are attempting to export sub-standard formulations, which do not conform to the composition declared on the containers/labels, and may be of little therapeutical value and may not conform to pharmacoepea; these drugs are .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X